Skip to search formSkip to main contentSkip to account menu

HFA 134a

Known as: HFA-134a, hydrofluoroalkane-134a 
National Institutes of Health

Related topics

Related topics

1 relation
apaflurane

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Surfactant solubility and aggregate orientation in hydrofluoroalkanes.
2004
2004
Characterization of Suspension-Based Metered Dose Inhaler Formulations Composed of Spray-Dried Budesonide Microcrystals Dispersed in HFA-134a
AbstractPurpose. To assess the physicochemical characteristics and aerosol properties of suspensions of lipid-coated budesonide… 
2003
2003
Multimodal particle size distributions emitted from HFA-134a solution pressurized metered-dose inhalers
The purpose of this research was to investigate the measurement and in vitro delivery implications of multimodal distributions… 
Highly Cited
2001
Highly Cited
2001
Characterisation of the aggregation behaviour in a salmeterol and fluticasone propionate inhalation aerosol system.
2001
2001
Extrafine beclomethasone dipropionate breath-actuated inhaler (400 micrograms/day) versus budesonide dry powder inhaler (800 micrograms/day) in asthma.
Hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol breath-actuated inhaler (Qvar Autohaler; BDP-AH) provides an… 
2001
2001
Switching from Ventolin CFC to Ventolin HFA is well tolerated and effective in patients with asthma.
1999
1999
Switching patients with asthma from chlorofluorocarbon (CFC) albuterol to hydrofluoroalkane-134a (HFA) albuterol.
Chlorofluorocarbon (CFC) propellants deplete stratospheric ozone. Production and use of CFCs, except for certain critical… 
1999
1999
Safety of long-term treatment with HFA albuterol.
BACKGROUND Chlorofluorocarbons (CFCs) used as propellants in metered-dose inhalers deplete stratospheric ozone, which results in… 
1996
1996
Twenty‐eight‐day Double‐blind Safety Study of an HFA‐134a Inhalation Aerosol System in Healthy Subjects
A 28‐day double‐blind parallel group study has been conducted to compare the safety and tolerability of HFA‐134a, a… 
Review
1995
Review
1995
An overview of the toxicology of HFA-134a (1,1,1,2-tetrafluoroethane)
1 This paper reviews the results of preclinical toxicology studies on HFA-134a carried out by Glaxo Research and Development Ltd… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)